Skip to main content
. 2018 Sep 10;11:1756286418796404. doi: 10.1177/1756286418796404

Table 4.

Frequency distribution of more common adverse events and serious adverse events in persons with relapsing remitting multiple sclerosis treated with dimethyl fumarate.

Dimethyl fumarate 62 (26.5), No. (%)
Adverse events Flushing, itch 31 (13.3)
Diarrhea, colitis 11 (5.6)
Epigastralgia, nausea 9 (3.8)
Lymphopenia 3 (2.1)
Increase of transaminases 2 (0.9)
Herpes zoster reactivation 1 (0.4)
Depression 1 (0.4)
Serious adverse events Severe lymphopenia 2 (0.9)
Severe diarrhea 2 (0.9)